GeneDx Holdings Corp.
WGS

$1.95 B
Marketcap
$71.04
Share price
Country
$6.64
Change (1 day)
$89.11
Year High
$1.41
Year Low

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

marketcap

GeneDx Holdings Corp. (WGS) - Company Outlook



Company Outlook

Year Receivables Debt Liabilities Assets Current Assets
2023 32.82 M 20.09 M 245.66 M 473.67 M 182.34 M
2022 43.34 M -51,549,000 237.24 M 490.94 M 212.62 M
2021 26.56 M -367,723,000 165.99 M 554.09 M 483.54 M
2020 32.33 M -63,107,000 581.69 M 251.64 M 174.11 M